Evofem Biosciences (EVFM) Stock Chart & Stock Price History $0.01 0.00 (0.00%) As of 07/3/2025 11:39 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evofem Biosciences Stock Price Performance The Evofem Biosciences (EVFM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 4.71%, with a year-to-date return of 1.01%. In the past month, the stock has increased 6.38%, reflecting recent market activity. As of the latest close, Evofem Biosciences traded at $0.01 with a market cap of $1.19 million and volume of 39,482 shares. Five years ago, the stock traded at a split-adjusted price of $5,587.50, representing a 100.00% decrease over that period. At the time, it had a market cap of $140.68 million and a volume of 23,945 shares. Receive EVFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.38%1 Month Performance+6.38%3 Month Performance+3.09%Year-To-Date Performance+1.01%1 Year Performance+4.71%5 Year Performance-100.00% EVFM Stock Chart for Friday, July, 4, 2025 EVFM Chart by TradingView Evofem Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$0.01$0.01$0.01$0.0139,482 shs$1.19 million07/02/2025$0.01$0.01+1.01%$0.01$0.01136,707 shs$1.19 million07/01/2025$0.01$0.01+1.02%$0.01$0.0187,469 shs$1.18 million06/30/2025$0.01$0.01+4.26%$0.01$0.01700,495 shs$1.16 million06/27/2025$0.01$0.01-1.05%$0.01$0.01532,372 shs$1.12 million06/26/2025$0.01$0.01+1.06%$0.01$0.01143,032 shs$1.13 million06/25/2025$0.01$0.01-2.08%$0.01$0.01104,378 shs$1.12 million06/24/2025$0.01$0.01-4.00%$0.01$0.0141,189 shs$1.14 million06/23/2025$0.01$0.01+3.09%$0.01$0.01186,067 shs$1.19 million06/20/2025$0.01$0.01$0.01$0.01191,629 shs$1.15 million Get the Latest News and Ratings for EVFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$0.01$0.01$0.01$0.01347,999 shs$1.15 million06/18/2025$0.01$0.01+1.04%$0.01$0.01347,999 shs$1.15 million06/17/2025$0.01$0.01+3.23%$0.01$0.01145,414 shs$1.14 million06/16/2025$0.01$0.01-7.00%$0.01$0.01257,703 shs$1.10 million06/13/2025$0.01$0.01$0.01$0.01675,248 shs$1.19 million06/12/2025$0.01$0.01$0.01$0.0135,608 shs$1.19 million06/11/2025$0.01$0.01$0.01$0.01904,553 shs$1.19 million06/10/2025$0.01$0.01$0.01$0.0179,160 shs$1.19 million06/09/2025$0.01$0.01+4.17%$0.01$0.01636,751 shs$1.19 million06/06/2025$0.01$0.01$0.01$0.01123,106 shs$1.14 million06/05/2025$0.01$0.01+2.13%$0.01$0.0165,143 shs$1.14 million06/04/2025$0.01$0.01-1.05%$0.01$0.01455,868 shs$1.12 million06/03/2025$0.01$0.01-4.04%$0.01$0.01123,482 shs$1.13 million Related Companies Matinas Biopharma Stock Price Chart Galecto Stock Price Chart Mustang Bio Stock Price Chart Soligenix Stock Price Chart Moleculin Biotech Stock Price Chart Redhill Biopharma Stock Price Chart InMed Pharmaceuticals Stock Price Chart Titan Pharmaceuticals Stock Price Chart Polyrizon Stock Price Chart Evoke Pharma Stock Price Chart Receive EVFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EVFM) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
